Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $) In Thousands	9 Months Ended
	Sep. 30, 2011	Sep. 30, 2010
Operating activities:
Net income (loss)	$ 10,203	$ (4,142)
Adjustments to reconcile net income (loss) to net cash (used in) from operating activities:
Depreciation and amortization	14,919	15,494
Amortization of deferred gain	(356)	(664)
Loss on sale of fixed assets	111	108
Unrealized losses on commodity hedges	1,571
Equity in earnings of joint venture	(8,958)	(3,973)
Dividends from joint venture	2,245	804
Deferred tax benefit	(2,294)	(7,963)
Share-based compensation expense	3,047	1,714
Excess tax benefits from share-based payment arrangements	(145)	(172)
Increase (decrease) from changes in:
Accounts receivable	(41,366)	(34,021)
Inventories	(58,323)	8,806
Prepaid expenses and other current assets	(2,458)	(2,603)
Other assets		2,428
Prepaid pension costs	(1,381)	(786)
Accounts payable	42,367	15,290
Accrued liabilities	(4,133)	6,432
Income taxes payable and receivable	7,771	8,475
Postretirement benefit obligations and other liabilities	(404)	376
Net cash (used in) from operating activities	(37,584)	5,603
Investing activities:
Capital expenditures	(8,236)	(5,061)
Proceeds from sale of fixed assets	217
Insurance proceeds	573
Net cash used in investing activities	(7,446)	(5,061)
Financing activities:
Short-term borrowings (repayments), net	33,571	(2,220)
Net borrowings on long-term revolving lines of credit	1,618	1,746
Repayments of long-term debt	(300)	(607)
Excess tax benefits from share-based payment arrangements	145	172
Exercise of stock options	240	279
Net cash from (used in) financing activities	35,274	(630)
Effect of exchange rate changes on cash and cash equivalents	(1,059)	(48)
Net decrease in cash and cash equivalents	(10,815)	(136)
Cash and cash equivalents - beginning of year	36,716	28,311
Cash and cash equivalents - end of period	$ 25,901	$ 28,175